PE
VERA icon

Point72 Europe’s Vera Therapeutics VERA Stock Holding History

Point72 Europe’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$35.7K Buy
+1,230
New +$28.4K ﹤0.01% 406

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 Europe's VERA Position: Q3 2025 in Review

Point72 Europe opened a new position in Vera Therapeutics (VERA) in Q3 2025: 1,230 shares worth $35.7K. The stake represents ﹤0.01% of the portfolio and ranks #406 among its holdings.

175 funds tracked by Wall St. Rank hold VERA as of Q3 2025.

  • Point72 Europe held 1,230 shares of Vera Therapeutics worth $35.7K as of Q3 2025.
  • Vera Therapeutics was a new Point72 Europe position in Q3 2025.
  • Vera Therapeutics made up ﹤0.01% of Point72 Europe's portfolio in Q3 2025, its #406 holding.
  • 175 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2025.

Based on Point72 Europe's 13F filing for Q3 2025, filed 14 Nov 2025.